BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
See today's BioWorld Asia
Home
» Film at eleventh hour: FDA Sunovion CRL asking more info but no further studies
To read the full story,
subscribe
or
sign in
.
Film at eleventh hour: FDA Sunovion CRL asking more info but no further studies
Feb. 6, 2019
By
Randy Osborne
Sunovion Pharmaceuticals Inc. stayed mostly mum on details regarding the FDA's complete response letter (CRL) related to the NDA for apomorphine sublingual film (APL-130277) to treat "off" episodes in Parkinson's disease (PD).
BioWorld Asia
